Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia
Acute Myeloid Leukaemia (AML) is a rare but serious group of diseases that require critical decision-making for curative treatment. Over the past decade, scientific discovery has revealed dozens of prognostic gene mutations for AML while sequencing costs have plummeted. In this study, we compared th...
Main Authors: | Cressman, S, Karsan, A, Hogge, DE, McPherson, E, Bolbocean, C, Regier, DA, Peacock, SJ |
---|---|
格式: | Journal article |
語言: | English |
出版: |
Wiley
2016
|
相似書籍
-
Quality of life and socioeconomic indicators associated with survival of myeloid leukemias in Canada
由: Sonya Cressman, et al.
出版: (2020-07-01) -
Acute Myeloid Leukaemia with Plasmacytosis
由: Yasmin Akhtar, Saqib Qayyum Ahmad, Shahid Jamal
出版: (2016-12-01) -
Exploring the acute myeloid leukaemias
由: TB Thapa
出版: (2013-10-01) -
Secondary acute myeloid leukaemia in children treated for acute lymphoblastic leukaemia.
由: Eden, O, et al.
出版: (1998) -
Acute myeloid leukaemia with aberrant expression of pancytokeratin: A diagnostic pitfall
由: Yasin Dhonye, et al.
出版: (2023-02-01)